Adherex Technologies (FENC)
(Delayed Data from NSDQ)
$9.14 USD
-0.07 (-0.76%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $9.14 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Adherex Technologies Inc. [FENC]
Reports for Purchase
Showing records 41 - 60 ( 102 total )
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARK Receives FDA Complete Response Letter, Resubmission Timelines Unclear
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
2Q20 Financials; PEDMARK PDUFA Date Ahead August 10
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
1Q20 Financials; Cash Replenished; Modulating PT to $15
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARK Application Accepted; Priority Review, as Expected; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
PEDMARK NDA Filing Accepted; Approval Anticipated by August 10 PDUFA Date
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
From Underneath The Rubble Sing a Rebel Song
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Patent Protection Prolongs PEDMARK Potential
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
Sodium Thiosulfate Application Accepted for Review in Europe; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Adherex Technologies Inc.
Industry: Medical - Drugs
2019 Financials Reported; PEDMARK Approval Decision Approaching; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R